Drug intelligence / Profile preview

Lishi-jiangzhi

Development stage: Preclinical
Administration: Oral

Overview

Lishi-jiangzhi appears to be a traditional Chinese medicine (TCM) formulation, likely used for metabolic or liver-related conditions. However, there is no direct evidence in the provided sources that specifically describes "Lishi-jiangzhi" as a unique, well-characterized product or formula. The name may refer to a TCM herbal combination aimed at "reducing fat" (as "Jiangzhi" means "reduce fat/lipid") and possibly improving liver health or treating fatty liver disease. Similar-sounding formulas such as Jianpi Lishi Jiedu granules and Qingre Lishi decoction are referenced in clinical studies for colorectal adenoma management and type 2 diabetes mellitus, respectively[3][6]. These formulas typically contain multiple herbal ingredients and are administered orally as granules or decoctions.

Brand names: Lishi-jiangzhi
Other names: Lishi-jiangzhi

Beyond the preview

Go deeper on Lishi-jiangzhi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lishi-jiangzhi.

Explore the full profile